Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration.

Authors:
Maruyama-Inoue M; Yanagi Y; Inoue T; Kadonosono K.

Journal:
Graefes Arch Clin Exp Ophthalmol

Publication Year: 2023

DOI:
10.1007/s00417-023-06241-8

PMCID:
PMC10844403

PMID:
37750953

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Graefes Arch Clin Exp Ophthalmol

Abbreviation: Graefes Arch Clin Exp Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A case study in applying artificial intelligence-based named entity recognition to develop an autom…
Macri CZ; Teoh SC; Bacchi S and 5 more (2023) - Transparency Score: 3/6
Accelerated corneal cross-linking (18mW/cm2 for 5 min) with HPMC-riboflavin in progressive keratoco…
Friedrich J; Sandner A; Nasseri A and 2 more (2023) - Transparency Score: 3/6
A mini-invasive surgical technique for Carlevale IOL implantation: case series study and descriptio…
Danese C; Di Bin F; Lanzetta P. (2023) - Transparency Score: 3/6
A novel quick contrast sensitivity function test in Chinese adults with myopia and its related para…
Ye Y; Aruma A; Zhao W and 3 more (2023) - Transparency Score: 3/6
A rabbit model for outer retinal atrophy caused by surgical RPE removal.
Al-Nawaiseh S; Krötz C; Rickmann A and 6 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalAll procedures performed in studies involving human participants were in accordance with the ethical standards of the Yokohama City University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consentInformed consent was obtained from all individual participants included in the study. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025